Skip to content

FHTX - Foghorn Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchF

Foghorn Therapeutics Inc

FHTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

F

FHTXFoghorn Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $7.61
52-wk low: $3.27
Prev close: $5.91
Mkt cap: $419.3M
Beta: 2.83
P/S: 10.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$48.6M

JS
Jim Simons
Q2 2026 13F
$1.8M
position
QR
Qube Research
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in 56.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -175.8%
Market cap: $419M

Valuation

P/S10.91
P/B2005.35

Quality

Operating margin-54.8%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: FHTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $419.26M
Beta: 2.83

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2005.3x

Profit margin

-175.8%

Op margin

-54.8%

ROE

-470.4%

$992K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$775K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for FHTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.10+56.5%

-$0.23 expected

Next report

What the street expects next

-470.4%

ROA-19.9%

Growth

Beta2.83